Key Reasons for the Ban: Lack of scientific and therapeutic rationale for combination use No added clinical benefit over individual drug therapy Increased risk of adverse drug reactions and drug interactions Potential contribution to antimicrobial resistance (in antibiotic combinations) Overall unnecessary burden on patients and healthcare systems Regulatory Action: The ban reflects Indias strengthened approach toward evidence-based medicine and rational drug use, ensuring that only safe, effective, and clinically justified drug combinations remain in the market
That voice says, Shut the fuck up and get in the cold water, pussy
Roughly 10% of reproductive-age women are affected, which translates to approximately 190 million people globally
Factors like your general health, metabolism, and treatment consistency can affect the treatment time
This process and its linkage with cytosolic GSL synthesis requires two transport steps across the chloroplast envelope, as the first reaction allowing Met to enter biosynthesis of GSLs is a deamination of Met by a cytosolic BCAT4 (Schuster et al., 2006)
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J
